期刊
TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 31, 期 2, 页码 93-106出版社
CELL PRESS
DOI: 10.1016/j.tem.2019.10.002
关键词
-
资金
- National Natural Science Foundation of China [81822034, 81773119]
- National Key Research and Development Program of China [2018YFA0109200, 2017YFA0106800]
- Sichuan Science-Technology International Cooperation Project [2019YFH0144]
- West China Second Hospital, Sichuan University [KS021, K1907]
- Robert A Welch Foundation [E-0004]
- Swedish Cancer Foundation
- National Institutes of Health [NIH CA217065]
- Center for Innovative Medicine
- Novo Nordisk Fund
Members of the nuclear receptor superfamily serve as master regulators in signaling by either positively or negatively regulating gene expression. Accumulating evidence has suggested that nuclear receptors are actively involved in immune responses, with specific roles in different immune cell compartments that contribute to both normal function and to disease development. The druggable properties of nuclear receptors have made them ideal modulatory therapeutic targets. Here, we revisit nuclear receptor biology, summarize recent advances in our understanding of the immunological functions of nuclear receptors, describe cell-type-specific roles and specific nuclear receptors in disease pathogenesis, and explore their potential as novel therapeutic targets. These nuclear receptor-dependent alterations in the immune system are amenable to pharmacological manipulation and suggest novel therapeutic strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据